nifedipine has been researched along with 6-ketoprostaglandin f1 alpha in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (40.74) | 18.7374 |
| 1990's | 13 (48.15) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akopov, SE; Gabrielian, ES; Grigorian, GS; Kazarian, AV; Mkhitarian, GS; Tunian, IuS | 1 |
| Kamanna, VS; Kirschenbaum, MA; Roh, DD | 1 |
| Arakawa, T; Durbin, T; Fukuda, T; Mach, T; Tarnawski, A | 1 |
| Manninen, A; Metsä-Ketelä, T; Tuimala, R; Vapaatalo, H | 1 |
| Yan, XF; Zhang, YZ | 1 |
| Flynn, JT; Hellerman, P; Shelly, MA | 1 |
| Kawashima, T; Kuroiwa, A; Nakashima, Y; Nandate, H; Yashiro, A | 1 |
| Blay, J; Hollenberg, MD | 1 |
| Dandona, P; Jeremy, JY; Mikhailidis, DP | 1 |
| Capponi, AM; Lew, PD; Vallotton, MB | 1 |
| el Din, MM; Malik, KU | 1 |
| Campese, V; Horton, R; McKay, M; Nadler, JL; Vrbanac, J | 1 |
| Darius, H; Klaus, W; Latta, G; Schrör, K; Ziegler, R | 1 |
| Blasevich, M; Borghi, A; Galli, C; Petroni, A; Socini, A | 1 |
| Barrow, SE; Conway, EL; Murphy, MB; Orchard, MA | 1 |
| Barst, RJ; Cato, AE; Frosolono, MF; Hall, JC; Mellins, RB; Stalcup, SA; Steeg, CN | 1 |
| Satoh, H; Satoh, S; Suzuki, J | 1 |
| Ito, T; Kai, I; Ogawa, K | 1 |
| Fujihira, S; Ishida, H; Mine, Y; Mitamura, T; Noguchi, H; Ohara, K; Yamada, A | 1 |
| Church, DJ; Lang, U; Vallotton, MB; Van der Bent, V | 1 |
| Drapeau, G; Grose, JH; Levesque, L; Marceau, F; Rioux, F | 1 |
| Descomps, B; Lobaccaro-Henri, C; Thaler-Dao, H | 1 |
| Braun-Dullaeus, RC; Feussner, M; Grimminger, F; Haberbosch, W; Hopmann, H; Kraemer, HJ; Tillmanns, H; Walker, G | 1 |
| Frank, DU; Horstman, DJ; McCall, DA; Rich, GF | 1 |
| Darlametsos, IE; Papanikolaou, EN; Varonos, DD | 1 |
| Brown, G; Losonczy, G; Schoenl, M; Venuto, R | 1 |
| Liu, X; Rohdewald, P; Tan, F; Wei, J; Würthwein, G; Zhou, S | 1 |
3 trial(s) available for nifedipine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
[Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Adult; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Humans; Male; Nifedipine; Nisoldipine; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1985 |
The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1 alpha, and its interaction with indomethacin.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Animals; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Interactions; Female; Humans; Hypertension; Indomethacin; Male; Middle Aged; Nifedipine; Platelet Aggregation; Random Allocation; Rats | 1985 |
Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Angiotensin II; Blood Chemical Analysis; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Endothelin-1; Female; Flavonoids; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitric Oxide; Pinus; Plant Extracts; Platelet Aggregation Inhibitors; Treatment Outcome | 2004 |
24 other study(ies) available for nifedipine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
[Status of the prostacyclin-thromboxane balance in patients with cerebrovascular disorders and the effect of the treatment with nifedipine].
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Cerebral Infarction; Cerebrovascular Circulation; Epoprostenol; Humans; Intracranial Arteriosclerosis; Middle Aged; Nifedipine; Thromboxane A2 | 1991 |
Effect of nifedipine on renal microvascular cholesterol accumulation and prostacyclin biosynthesis in cholesterol-fed rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Kidney; Microcirculation; Nifedipine; Rabbits | 1991 |
Calcium channel blockers and prostaglandin generation by gastric surface epithelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcium; Calcium Channel Blockers; Calmodulin; Diltiazem; Dinoprostone; Epithelium; Gastric Mucosa; Male; Nifedipine; Rats; Rats, Inbred Strains; Sulfonamides; Verapamil | 1991 |
Nifedipine increases urinary excretion of prostacyclin metabolite in hypertensive pregnancy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Pressure; Catecholamines; Creatinine; Dinoprostone; Epoprostenol; Female; Humans; Hypertension; Kallikreins; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Prostaglandins; Thromboxane B2 | 1991 |
[Effects of nifedipine and Paeonia lactiflora on plasma TXB2 and 6-Keto-PGF1 alpha in cholesterol-fed rabbits].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cholesterol, Dietary; Drugs, Chinese Herbal; Hyperlipidemias; Male; Nifedipine; Rabbits; Thromboxane B2 | 1990 |
Zymosan-activated plasma-mediated thromboxane production by the perfused rabbit liver and isolated hepatocytes: involvement of calcium.
Topics: 6-Ketoprostaglandin F1 alpha; Acid Phosphatase; Animals; Blood; Calcium; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Nifedipine; Perfusion; Rabbits; Thromboxane B2; Zymosan | 1990 |
Sustained-release nifedipine (nifedipine-L) suppresses plasma thromboxane B2 and 6-keto prostaglandin F1 alpha in both young male smokers and nonsmokers.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Pressure; Delayed-Action Preparations; Diastole; Heart Rate; Humans; Male; Nifedipine; Smoking; Thromboxane B2; Triglycerides | 1990 |
Epidermal growth factor stimulation of prostacyclin production by cultured aortic smooth muscle cells: requirement for increased cellular calcium levels.
Topics: 6-Ketoprostaglandin F1 alpha; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium Chloride; Cell Line; Cyclic GMP; Epidermal Growth Factor; Gallic Acid; Kinetics; Muscle, Smooth, Vascular; Nifedipine; Tetradecanoylphorbol Acetate | 1989 |
The effect of nifedipine, nimodipine and nisoldipine on agonist- and trauma-stimulated vascular prostacyclin synthesis in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Calcium Channel Blockers; Epinephrine; Epoprostenol; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Wounds and Injuries | 1986 |
Effect of serotonin on cytosolic free calcium in adrenal glomerulosa and vascular smooth muscle cells.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenal Glands; Animals; Calcium; Cattle; Cells, Cultured; Cytosol; Epoprostenol; In Vitro Techniques; Ketanserin; Muscle, Smooth, Vascular; Nifedipine; Rats; Serotonin | 1987 |
Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcium; Calmodulin; Diltiazem; In Vitro Techniques; Kidney; Male; Neuropeptide Y; Nifedipine; Norepinephrine; Prostaglandins; Rats; Rats, Inbred Strains; Trifluoperazine; Vasoconstriction | 1988 |
Evidence that prostacyclin modulates the vascular actions of calcium in man.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Pressure; Calcium; Creatinine; Dinoprostone; Drug Interactions; Epoprostenol; Hemodynamics; Humans; Ibuprofen; Indomethacin; Kidney; Natriuresis; Nifedipine; Potassium; Prazosin; Prostaglandins E; Regional Blood Flow; Sulindac; Vascular Resistance; Vasodilation | 1986 |
Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain; Dipyridamole; Male; Microwaves; Nifedipine; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasomotor System | 1985 |
Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child.
Topics: 6-Ketoprostaglandin F1 alpha; Aging; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Diltiazem; Epoprostenol; Female; Hemodynamics; Humans; Infant; Nifedipine; Pulmonary Artery; Pulmonary Circulation; Thromboxane B2; Vascular Diseases; Vasodilation | 1985 |
Effects of calcium antagonists and calmodulin inhibitors on angiotensin II-induced prostaglandin productions in the isolated dog renal arteries.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Calcium Channel Blockers; Calmodulin; Dinoprostone; Dogs; Egtazic Acid; Female; Gallic Acid; Male; Nifedipine; Prostaglandins; Prostaglandins E; Renal Artery; Sulfonamides; Verapamil | 1985 |
Effects of peripheral vasodilation caused by verapamil, nifedipine, and nitroglycerin on plasma prostaglandins and thromboxane concentrations.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Dinoprost; Dogs; Female; Male; Nifedipine; Nitroglycerin; Prostaglandins; Prostaglandins E; Prostaglandins F; Pyridines; Thromboxane B2; Thromboxanes; Vascular Resistance; Vasodilation; Verapamil | 1982 |
Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterioles; Blood Urea Nitrogen; Creatinine; Hypertension; Kidney; Kidney Diseases; Male; Nifedipine; Rats; Rats, Inbred SHR; Renal Artery; Renin; Tacrolimus; Thromboxane B2; Vasoconstriction | 1994 |
Role of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Atrial Natriuretic Factor; Bucladesine; Cells, Cultured; Cyclic AMP; Diclofenac; Dinoprost; Dinoprostone; Epoprostenol; Heart; Heart Ventricles; Indomethacin; Kinetics; Myocardial Contraction; Myocardium; Nifedipine; Prostaglandins; Protein Kinase C; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Thionucleotides | 1994 |
Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Thoracic; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Cells, Cultured; Female; Guanylate Cyclase; In Vitro Techniques; Indomethacin; Inositol Phosphates; Lipoxygenase Inhibitors; Male; Models, Biological; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Protein Kinase Inhibitors; Rabbits; Receptors, Bradykinin; Signal Transduction | 1993 |
RU 38486 inhibits intracellular calcium mobilization and PGI2 release from human myometrium: mechanisms of action.
Topics: 6-Ketoprostaglandin F1 alpha; Abortifacient Agents, Steroidal; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Drug Synergism; Endoplasmic Reticulum; Enzyme Inhibitors; Epoprostenol; Female; Gallic Acid; Hormone Antagonists; Humans; Intracellular Fluid; Mifepristone; Muscle Relaxation; Myometrium; Nifedipine; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Staurosporine; Structure-Activity Relationship; Thapsigargin; Uterine Contraction | 1996 |
Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Cyclooxygenase Inhibitors; Cyclosporine; Endothelium, Vascular; Heart; Heart Rate; Immunosuppressive Agents; Male; Myocardial Contraction; Myocardium; Nifedipine; Nitric Oxide Donors; Nitroglycerin; Pharmaceutical Vehicles; Polyethylene Glycols; Prostanoic Acids; Rats; Rats, Wistar; Receptors, Thromboxane; Thromboxane B2; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Inhaled nitric oxide and nifedipine have similar effects on lung cGMP levels in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Inhalation; Animals; Bronchodilator Agents; Cyclic AMP; Cyclic GMP; Down-Regulation; Enzyme Inhibitors; Epoprostenol; Hypertension, Pulmonary; Hypoxia; Lung; Male; Monocrotaline; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Poisons; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1999 |
Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Calcium Channel Blockers; Creatinine; Cyclosporine; Dinoprostone; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Female; Immunoassay; Kidney; Nifedipine; Proteinuria; Rats; Rats, Wistar; Spectrophotometry; Thromboxane B2; Urine | 2000 |
Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 6-Ketoprostaglandin F1 alpha; Anesthesia; Animals; Aorta; Blood Pressure; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiac Output; Consciousness; Dihydropyridines; Female; Heart Rate; Muscle, Smooth, Vascular; Nifedipine; Pregnancy; Pregnancy, Animal; Rabbits; Thromboxane B2; Tritium | 2002 |